Literature DB >> 10708306

High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T.

J Sundin1, V Tolmachev, J Koziorowski, J Carlsson, H Lundqvist, S Welt, S Larson, A Sundin.   

Abstract

Monoclonal antibody (MAb) A33 was labeled with the positron emitter 76Br (T(1/2) = 16.2 h). Direct labeling was done using the conventional chloramine-T method. After optimization of the labeling conditions, a maximum yield (mean +/- max error) of 77 +/- 2% was obtained at pH 6.8. In vitro binding of 76Br-A33 to SW1222 colonic cancer cells showed that the immunoreactivity was retained. Also, the MAbs 38S1 and 3S193 and the peptide hEGF were 76Br-labeled, resulting in labeling yields (mean +/- max error) of 75 +/- 3%, 63 +/- 4%, and 73 +/- 0.1%, respectively. We conclude that antibodies and peptides can be labeled conveniently with 76Br for the purpose of whole-body tumour imaging by positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10708306     DOI: 10.1016/s0969-8051(99)00076-1

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  5 in total

1.  ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.

Authors:  Ferid Haddad; Ludovic Ferrer; Arnaud Guertin; Thomas Carlier; Nathalie Michel; Jacques Barbet; Jean-François Chatal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

2.  New Methods for Labeling RGD Peptides with Bromine-76.

Authors:  Lixin Lang; Weihua Li; Hong-Mei Jia; De-Cai Fang; Shushu Zhang; Xilin Sun; Lei Zhu; Ying Ma; Baozhong Shen; Dale O Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011-08-22       Impact factor: 11.556

Review 3.  Radiolabeled Dendrimers for Nuclear Medicine Applications.

Authors:  Lingzhou Zhao; Meilin Zhu; Yujie Li; Yan Xing; Jinhua Zhao
Journal:  Molecules       Date:  2017-08-25       Impact factor: 4.411

Review 4.  Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology.

Authors:  Christine Rangger; Roland Haubner
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-30

Review 5.  Dendrimer-based contrast agents for PET imaging.

Authors:  Lingzhou Zhao; Xiangyang Shi; Jinhua Zhao
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.